ML vs. LLY

Last updated Apr 1, 2026

Compare and contrast key facts about MoneyLion Inc. (ML) and Eli Lilly and Company (LLY).

Performance

ML vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MoneyLion Inc. (ML) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

ML vs. LLY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
ML MoneyLion Inc.	0.00%	-0.13%	37.20%	237.04%	-84.62%	-64.34%	15.31%
LLY Eli Lilly and Company	-14.27%	40.25%	33.30%	60.91%	34.26%	66.08%	13.07%

Fundamentals

Total Revenue (TTM) ML : $545.91M LLY : $65.18B
Gross Profit (TTM) ML : $409.26M LLY : $54.62B
EBITDA (TTM) ML : $56.96M LLY : $27.94B

Returns By Period

ML

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

LLY

• 1D: 3.74%
• 1M: -12.57%
• YTD: -14.27%
• 6M: 20.93%
• 1Y: 12.19%
• 3Y*: 39.90%
• 5Y*: 39.16%
• 10Y*: 30.92%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ML vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LLY

LLY Risk / Return Rank: 51
LLY Sharpe Ratio Rank: 53
LLY Sortino Ratio Rank: 48
LLY Omega Ratio Rank: 49
LLY Calmar Ratio Rank: 53
LLY Martin Ratio Rank: 54

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ML vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for MoneyLion Inc. (ML) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	ML	LLY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.29	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	1.23	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	1.04	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.56	—

Correlation

The correlation between ML and LLY is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ML vs. LLY - Dividend Comparison

ML has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.68%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ML MoneyLion Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
LLY Eli Lilly and Company	0.68%	0.56%	0.67%	0.78%	1.07%	1.23%	1.75%	1.96%	1.94%	2.46%	2.77%	2.37%

Drawdowns

Drawdown Indicators

	ML	LLY	Difference
Max Drawdown Largest peak-to-trough decline	—	-68.24%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-30.26%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-34.48%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-34.48%	—
Current Drawdown Current decline from peak	—	-17.00%	—
Average Drawdown Average peak-to-trough decline	—	-19.25%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	12.39%	—

Volatility

Volatility by Period

	ML	LLY	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	9.04%	—
Volatility (6M) Calculated over the trailing 6-month period	—	26.21%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	42.44%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	32.14%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	29.80%	—

Financials